Active ingredientSofpironium BromideCat. No. P-S057-001CAS 1628106-94-4Family · Pharmaceutical analytical standards
Sofpironium
An anticholinergic gel applied to the skin of the armpits for primary axillary hyperhidrosis, that is, excessive sweating: approved in Japan in 2020 and in the United States in 2024. This family brings together the active ingredient and other impurities.
Did you know?It comes from "retrometabolic design", a strategy that plans medicines from the outset around how the body will transform them, so that they act mainly where they are applied.
Go to the active ingredient →Active ingredientSofpironium BromideCat. No. P-S057-001CAS 1628106-94-4
ImpuritySofpironium Impurity 1Cat. No. P-S057-002CAS 1027790-67-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.